One of the things that makes medical care at major academic medical centers like UAB special is the scientific discovery that unfolds daily that helps us understand biological mechanisms in ways that lead to better care for people suffering injury or disease.
The program offers adults 18 and older considered most at risk for type 2 diabetes an evidence-based program that can help prevent or delay the disease through lifestyle changes.
Researchers found differences in polymerase chains thought to be similar, potentially opening new pathways toward cancer drug development.
As part of the award, Peter Anderson, D.V.M., Ph.D., director of Pathology Undergraduate Education, will lead faculty development programs and hands-on workshops at the Tzu-Chi University College of Medicine in Taiwan for two weeks.
Study explains how the brain remembers pleasure and its implications for addiction
Written by Greg Williams
Molecular events that form such “reward memories” appear to differ from those created by drug addiction, despite the popular theory that addiction hijacks normal reward pathways.
Discovery leads researchers to redouble efforts to design a new class of drugs to treat diabetes.
Researchers show long-term efficacy of the first FDA approved drug for vasculitis.
The new Viral Hepatitis Clinic offers patients the latest therapies and follows the treatment model in HIV care pioneered by the 1917 Clinic.
The Division of Neurosurgery’s 15 residents to published 75 articles in peer-reviewed medical journals last year.
As part of a UAB study, physicians are completing a survey on their understanding of patient attitudes and misperceptions about generic medications.